摘要
目的研究泮托拉唑短程四联4、5、7d疗法根除幽门螺杆菌(Hp)的疗效。方法166例经胃镜证实Hp阳性的重度胃炎患者随机分为泮托拉唑四联疗法4d组、5d组和7d组,均给予泮托拉唑40mg+枸橼酸铋钾220mg+克拉霉素250mg+阿莫西林1g,每日2次治疗,泮托拉唑疗程1周,枸橼酸铋钾疗程2周,克拉霉素、阿莫西林疗程在3组分别为4、5和7d。疗程结束4周后复查Hp,观察Hp根除率、症状缓解率及不良反应等。结果泮托拉唑四联疗法4、5和7d组Hp根除率分别为73.8%(45/61)、75.9%(41/54)和80.4%(41/51);疼痛缓解率分别为82.4%(42/51)、85.1%(40/47)和88,9%(40/45),各组之间比较差异均无统计学意义(均P〉0.05)。结论泮托拉唑四联短程疗法(4或5d)为安全、有效、符合药物经济学要求的根除Hp的方案。
Objective To compare the efficacy of pantoprazole based short-term quadruple regimens in the treatment of Helicobacter pylori ( H. pylori) infection for 4 days,5 days or 7days. Methods 166 patients with H. pylori associated severe gastritis were randomly divided into pantoprozole quadruple regimens of 4-day group ( n = 61 ) ,5-day group ( n =54) or 7-day group ( n = 51 ). The regimen was pantoprazole 40 mg,bismuth potassium citrate 220 mg,clarithromycin 250 mg and amoxicillin 1 g twice daily. The patients received pantoprazole for 1 week, bismuth potassium citrate for 2 weeks,clarithromycin and amoxicillin for 4 days,5 days or 7 days respectively. The H. pylori eradication and symptomatic relief was determinded by ^13 C-UBT at least 4 weeks after the therapy. Results The H. pylori eradication rates of 4-day,5-day or 7-day pantoprazole quadruple regimens were 73.8% (45/61) ,75. 9% (41/54) and 80.4% (41/51) respectively. The pain relief rates were 82, 4% (42/51) ,85.1% (40/47) and 88.9% ( 40/45 ) in 4-day,5-day and 7 day group. Conclusion The 4-day and 5- day pantoprazole based quadrual therapy is a shortterm, effective, safe and lower therapeuticcost regimen for H. pylori eradication.
出处
《中国综合临床》
北大核心
2008年第8期782-784,共3页
Clinical Medicine of China
关键词
胃炎
幽门螺杆菌
泮托拉唑
短程四联疗法
Gastritis
Helicobater pylori
Pantoprazole
Short-term quadrual regimen